Search results

Calibrating the assays of bivalirudin using anti-IIa methods, especially with HEMOCLOT Thrombin Inhibitors kit (ref. CK002K, CK002L) or BIOPHEN DTI (ref. 220202).

Quality control of clotting assays proposed for measuring bivalirudin concentrations in plasma (especially ref. CK002K, CK002L and 220202).

Determination of prothrombin time (PT) in human citrated plasma.

Determination of prothrombin time (PT) in human citrated plasma.

Determination of prothrombin time (PT) in human citrated plasma.

Quality control of a modified one-stage FVIII activity assay for determination of active emicizumab concentration from a clot time measurement performed on an automated coagulation analyzer.

Calibration of a modified one-stage FVIII activity assay for determination of active emicizumab concentration from a clot time measurement performed on an automated coagulation analyzer.

For any in vitro protocol or research study where a source of human TAFI deficient plasma is required.

Assay proposed for the measurement of heparin anti-thrombin activity in research applications acc. to Pharmacopoeia.

Reagent with low phospholipid concentration for confirming the presence of lupus anticoagulants (LA). The presence of LA does not or only insignificantly prolong clotting time.